Search Results

CSL Seqirus, a Global Leader in Pandemic Preparedness and Outbreak Response, Signs an Agreement with the European Commission to Support Pandemic Preparedness Plans

https://newsroom.csl.com/2025-04-29-CSL-Seqirus,-a-Global-Leader-in-Pandemic-Preparedness-and-Outbreak-Response,-Signs-an-Agreement-with-the-European-Commission-to-Support-Pandemic-Preparedness-Plans

CSL Seqirus provides innovative solutions for pandemic preparedness and response.

https://www.csl.com/patients-public-health/vaccines/pandemic-response

Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract

https://newsroom.csl.com/2026-03-05-Canada-and-CSL-Seqirus,-a-Global-Leader-in-Influenza-Vaccines,-agree-on-new-Pandemic-Preparedness-Contract

CSL to access late-stage next-generation mRNA platform technology, enabling development of vaccines for COVID-19, influenza, multi-pathogen pandemic preparedness and other respiratory pathogens

https://newsroom.csl.com/2022-12-12-CSL-Announces-Closing-of-Global-Collaboration-and-Licensing-Agreement-with-Arcturus-Therapeutics

Cell-based influenza vaccine manufacturing is well suited to enabling pandemic preparedness as it reduces reliance on large volumes of critical materials and is a modern, efficient and highly scalable alternative to traditional manufacturing methods.

https://newsroom.csl.com/2025-10-30-CSL-Seqirus-and-Vaccine-Industrial-Company-sign-landmark-Memorandum-of-Understanding-with-Ministry-of-Health-to-localize-manufacturing-of-cell-based-seasonal-and-pandemic-influenza-vaccines

The partnership will strengthen vaccine manufacturing capacity in the region and support sustainable, reliable, scalable regional supply, laying a foundation for future pandemic preparedness.

https://newsroom.csl.com/2026-06-11-CSL-Seqirus-Signs-Long-Term-Agreement-with-The-Pan-American-Health-Organization-PAHO-to-Advance-Regional-Influenza-Protection-in-the-Region-of-the-Americas

Steve Marlow, CSL Seqirus General Manager, added "Importantly, it is another step towards our long-term aim to advance public health by developing and commercializing enhanced vaccines for influenza and multi-pathogen pandemic preparedness.

https://newsroom.csl.com/2022-11-01-CSL-Enters-Licensing-Agreement-with-Arcturus-Therapeutics-for-Next-Generation-mRNA-Vaccine-Technology

We are a diverse collective of people after one goal - to reimagine, reinvent and find new answers that save, improve and protect life.

https://www.csl.com/we-are-csl

CSL is committed to pricing practices that reflect the value our products bring to patients and society.

https://www.csl.com/sustainability/healthier-communities/access-and-affordability

CSL Seqirus, a Global Leader in Pandemic Preparedness and Outbreak Response, Signs an Agreement with the European Commission to Support Pandemic Preparedness Plans

https://newsroom.csl.com/csl-seqirus